Reduction in the ratio of β-preprotachykinin to preproenkephalin messenger RNA expression in postmortem human putamen during aging and in patients with status lacunaris. Implications for the susceptibility to parkinsonism

Brain Research

Volumn 768, Issue 1-2, 1997, Pages 86-90

  Tohgi, Hideo ^a   Utsugisawa, Kimiaki ^a   Yoshimura, Masahiro ^b   Yamagata, Munehisa ^a   Nagane, Yuriko ^a   Saitoh, Koh ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL EXAMINER S OFFICE   (Japan)

Author keywords

Aging; Ischemia; Polymerase chain reaction; Preproenkephalin; Preprotachykinin; Striatum

Indexed keywords

4 AMINOBUTYRIC ACID; ENKEPHALIN; MESSENGER RNA; NEUROPEPTIDE K; PREPROENKEPHALIN; SUBSTANCE P;

ADULT; AGED; AGING; ARTICLE; BRAIN INFARCTION; CONTROLLED STUDY; DISEASE PREDISPOSITION; HUMAN; HUMAN TISSUE; MALE; PARKINSONISM; PRIORITY JOURNAL; PUTAMEN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; AGING; CEREBRAL INFARCTION; DISEASE SUSCEPTIBILITY; ENKEPHALINS; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PROTEIN PRECURSORS; PUTAMEN; RNA, MESSENGER; TACHYKININS; TRANSCRIPTION, GENETIC;

EID: 0030849518     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00570-2     Document Type: Article

References (32)

1. Agid Y., Javoy-Agid F. Peptides and Parkinson's disease. Trends Neurosci. 8:1985;30-35.
2. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12:1989;366-375.
3. Albin R.L., Reiner A., Anderson K.D., Penney J.B., Young A.B. Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia. Ann. Neurol. 27:1990;357-365.
4. Alexander G.E., Crutcher M.D. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 13:1990;266-271.
5. Beal M.F., Walker L.C., Storey E., Seger L., Price D.L., Cork L.C. Neurotransmitters in neocortex of aged rhesus monkeys. Neurobiol. Aging. 12:1991;407-412.
6. Buck S.P., Deshmukh P.P., Burks T.F., Yamamura H.I. A survey of substance P, somatostatin and neurotensin levels in ageing in the rat and human central nervous system. Neurobiol. Aging. 2:1981;257-264.
7. M.B. Carpenter, Anatomy of the corpus striatum and brain stem integrating system, in: V.B. Brooks (Ed.), Handbook of Physiology (Sect. 1: The nervous system II), American Physiological Society, 1981, pp. 947-995.
8. Clemens J.A., Phebus L.A. Dopamine depletion protects striatal neurons from ischemia-induced cell death. Life Sci. 42:1988;707-713.
9. Crossman A.R. Primate models of dyskinesia: the experimental approach to the study of basal ganglia-related involuntary movement disorders. Neuroscience. 21:1987;1-40.
10. De Ceballos M.L., Boyce S., Taylor M., Jenner P., Marsden C.D. Age-related decreases in the concentration of Met- and Leu-enkephalin and neurotensin in the basal ganglia of rats. Neurosci. Lett. 75:1987;113-117.
11. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13:1990;281-285.
12. D. Denny-Brown, The Basal Ganglia and their Relation to Disorders of Movements, Oxford University Press, 1962, pp. 37-44.
13. Di Chiara G., Morelli M., Consolo S. Modulatory functions of neurotransmitters in the striatum: A Ch/dopamine/NMDA interactions. Trends Neurosci. 17:1994;228-233.
14. Dupont A., Savard P., Merand Y., Labrie F., Boissier J.R. Age-related changes in central nervous system enkephalins and substance P. Life Sci. 29:1981;2317-2322.
15. Globus M.Y.T., Ginsberg M.D., Harik S.I., Busto R., Dietrich W.D. Role of dopamine in ischemic striatal injury: metabolic evidence. Neurology. 37:1987;1712-1719.
16. J. Glowinski, T. Michelot, A. Cheramy, Role of striato-nigral substance P in the regulation of the activity of the nigro-striatal dopaminergic neurones, in: E. Costa, M. Trabucchi (Eds.), Neural Peptides and Neuronal Communication, Raven, New York, 1980, pp. 51-63.
17. Harmar A.J., Armstrong A., Pascall J.C., Chapman K., Rosie R., Curtis A., Going J., Edwards C.R.W., Fink G. cDNA sequence of human β-preprotachykinin, the common precursor to substance P and neurokinin A. FEBS Lett. 208:1986;67-72.
18. Mauborgne A., Javoy-Agid F., Legrand J.C., Agid Y., Cesselin F. Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains. Brain Res. 268:1983;167-170.
19. E. McGeer, P.L. McGeer, Neurotransmitter metabolism in the aging brain, in: R.D. Terry, S. Gershon (Eds.), Neurobiology of Aging, Raven, New York, 1976, pp. 389-403.
20. McGeer P.L., Boulding J.E., Gibson W.C., Foulkes R.G. Drug induced extrapyramidal reactions: their treatment with diphenhydramine hydrochloride and dihydroxyphenylalanine. J. Am. Med. Assoc. 177:1961;665-670.
21. Murrow R.W., Schweiger G.D., Kepes J.J., Koller W.C. Parkinsonism due to a basal ganglia lacunar state: Clinicopathologic correlation. Neurology. 40:1990;897-900.
22. Nakayama H., Yokoi H., Fujita J. Quantification of mRNA by non-radioactive RT-PCR and CCD imaging system. Nucleic Acids Res. 20:1992;4939.
23. Noda M., Teranishi Y., Yakahashi H., Toyosato M., Notake M., Nakanishi S., Numa S. Isolation and structural organization of the human preproenkephalin gene. Nature. 297:1982;431-434.
24. Parent A. Extrinsic connections of the basal ganglia. Trends Neurosci. 13:1990;254-258.
25. A. Pert, L.A. Dewald, H. Liao, C. Sivit, Effects of opiates and opioids on motor behaviors: sites and mechanisms of action, in: E. Usdin, W.E. Bunney, N.S. Kline (Eds.), Endorphins in Mental Health Research, Oxford University Press, 1979, pp. 45-61.
26. Reiner A., Albin R.L., Anderson K.D., D'Amato C.J., Penney J.B., Young A.B. Differential loss of striatal projection neurons in Huntington disease. Proc. Natl. Acad. Sci. USA. 85:1988;5733-5737.
27. 2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience. 49:1992;285-296.
28. Smeyne R.J., Vendrell M., Hayward M., Baker S.J., Miao G.G., Schilling K., Robertson L.M., Curran T., Morgan J.I. Continuous c-fos expression precedes programmed cell death in vivo. Nature. 363:1993;166-169.
29. Storey E., Beal M.F. Neurochemical substrates of rigidity and chorea in Huntington's disease. Brain. 116:1993;1201-1222.
30. Sutherland J.C., Lin B., Monteleone D.C., Mugavero J., Sutherland B.M., Trunk J. Electronic imaging system for direct and rapid quantitation of fluorescence from electrophoretic gels: application to ethidium bromide-stained DNA. Anal. Biochem. 163:1987;446-457.
31. 5-enkephalin in the human brain. Brain Res. 280:1983;379-382.
32. Tolosa E.S., Santamaria J. Parkinsonism and basal ganglia infarcts. Neurology. 34:1984;1516-1518.